Literature DB >> 29237197

[Evaluation of Suicide Risk Levels in Hospitals: Validity and Reliability Tests].

Sandro Macagnino1, Tilman Steinert1, Carmen Uhlmann1.   

Abstract

OBJECTIVE: Examination of in-hospital suicide risk levels concerning their validity and their reliability.
METHOD: The internal suicide risk levels were evaluated in a cross sectional study of in 163 inpatients. A reliability check was performed via determining interrater-reliability of senior physician, therapist and the responsible nurse. Within the scope of the validity check, we conducted analyses of criterion validity and construct validity.
RESULTS: For the total sample an "acceptable" to "good" interrater-reliability (Kendalls W = .77) of suicide risk levels were obtained. Schizophrenic disorders showed the lowest values, for personality disorders we found the highest level of interrater-reliability. When examining the criterion validity, Item-9 of the BDI-II is substantial correlated to our suicide risk levels (ρm = .54, p < .01). Within the scope of construct validity check, affective disorders showed the highest correlation (ρ = .77), compatible also with "convergent validity". They differed with schizophrenic disorders which showed the least concordance (ρ = .43).
CONCLUSION: In-hospital suicide risk levels may represent an important contribution to the assessment of suicidal behavior of inpatients experiencing psychiatric treatment due to their overall good validity and reliability. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 29237197     DOI: 10.1055/s-0043-119244

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  1 in total

1.  Seclusion as a coercive measure in suicidality - daily routine or exception?

Authors:  Natalija Gavrilovic Haustein; Maurice Freudiger; Anna Hunziker; Urs Hepp; Lena Jellestad; Roland von Känel; Niklaus Stulz
Journal:  BMC Psychiatry       Date:  2022-06-25       Impact factor: 4.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.